STOCK TITAN

Nantahala & Principals Disclose 9.99% Position in DarioHealth (DRIO)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

DarioHealth Corp. reporting persons Nantahala Capital Management, LLC and principals Wilmot B. Harkey and Daniel Mack disclose beneficial ownership of 4,690,019 shares, representing 9.99% of the outstanding common stock as of June 30, 2025. The disclosed position includes 2,997,716 shares that may be acquired within 60 days through the exercise of warrants, and all voting and dispositive power is reported as shared rather than sole. Nantahala identifies two advised funds with rights to receive proceeds or dividends from more than 5% of the shares reported.

Positive

  • Significant disclosed stake: 4,690,019 shares reported, demonstrating substantial economic interest in DRIO
  • Transparency on exercisable warrants: Filing explicitly states 2,997,716 shares may be acquired within 60 days
  • Identification of economic beneficiaries: Specific funds advised by Nantahala are named as having rights to proceeds or dividends

Negative

  • Position just below 10%: Reported ownership is 9.99%, which avoids certain regulatory thresholds that apply at or above 10%
  • All power is shared: No sole voting or dispositive power reported, limiting clarity on who would act unilaterally

Insights

TL;DR: Nantahala and two principals report a near-10% shared stake, including exercisable warrants that could increase effective ownership.

The Schedule 13G/A shows a meaningful but sub-10% position in DRIO of 4,690,019 shares (9.99%), including 2,997,716 warrant-based shares exercisable within 60 days. Shared voting and dispositive power indicates control is exercised collectively through the adviser and named principals. The position is large enough to be material to investors but remains below 10%, avoiding certain reporting triggers. Identification of specific advised funds clarifies who economically benefits from the holdings.

TL;DR: Reporting persons disclose collective influence but not sole control; governance impact depends on coordination among stakeholders.

The filing classifies Nantahala as an investment adviser and Messrs. Harkey and Mack as control persons regarding the shares held by funds under Nantahala's control. All reported voting and dispositive power is shared, which suggests decisions are made through the adviser/fund structure rather than by a single individual. The disclosure that certain advised funds have the right to receive proceeds clarifies economic beneficiaries, which is important for assessing potential governance actions.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Nantahala Capital Management, LLC
Signature:/s/ Taki Vasilakis
Name/Title:Taki Vasilakis / Chief Compliance Officer
Date:08/14/2025
Wilmot B. Harkey
Signature:/s/ Wilmot B. Harkey
Name/Title:Wilmot B. Harkey
Date:08/14/2025
Daniel Mack
Signature:/s/ Daniel Mack
Name/Title:Daniel Mack
Date:08/14/2025

FAQ

How many DarioHealth (DRIO) shares does Nantahala report owning?

The filing reports 4,690,019 shares beneficially owned by Nantahala and the named principals.

What percentage of DRIO does the reported position represent?

The reported position represents 9.99% of DarioHealth's outstanding common stock as of June 30, 2025.

Does the filing include shares that can be acquired soon?

Yes. The 4,690,019 total includes 2,997,716 shares that may be acquired within 60 days through the exercise of warrants.

Do the reporting persons have sole voting or dispositive power over the shares?

No. The filing reports 0 shares with sole voting or dispositive power and 4,690,019 shares with shared voting and dispositive power.

Which funds are identified as economic beneficiaries of the reported shares?

The filing names Nantahala Capital Partners Limited Partnership and Blackwell Partners LLC - Series A as funds advised by Nantahala with rights to proceeds or dividends.
Dariohealth Corp

NASDAQ:DRIO

View DRIO Stock Overview

DRIO Rankings

DRIO Latest News

DRIO Latest SEC Filings

DRIO Stock Data

61.69M
5.19M
Health Information Services
Surgical & Medical Instruments & Apparatus
Link
United States
NEW YORK